Stoke Therapeutics Inc buy BTIG Research
Start price
18.08.25
/
50%
€15.60
Target price
18.08.26
€23.93
Performance (%)
70.51%
Price
14.01.26
€26.60
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Stoke Therapeutics Inc has seen massive gains of 70.51%. This prediction currently runs until 18.08.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -11.921% | -11.921% |
| iShares Core DAX® | 0.721% | 4.566% |
| iShares Nasdaq 100 | -0.413% | 1.884% |
| iShares Nikkei 225® | 3.500% | 7.196% |
| iShares S&P 500 | 0.489% | 2.436% |
Comments by BTIG_Research for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) was given a new $28.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by BTIG_Research for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€19.00
05.11.25
05.11.25
€33.93
05.11.26
05.11.26
40.00%
14.01.26
14.01.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
14.10.25
14.10.25
€33.70
14.10.26
14.10.26
0.00%
14.01.26
14.01.26